Bria-IMT demonstrates a median overall survival of 15.6 months, surpassing historical data for heavily pretreated metastatic ...

Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or ...

Detailed price information for Briacell Therapeutics Corp (BCT-T) from The Globe and Mail including charting and trades.

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

BriaCell patients treated since 2022 remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for ...

Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in ...

Kazia Therapeutics , today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), ...

Longer follow-up of the ASPREE cohort is warranted, says researcher ...

Recent developments in oncology have increasingly focused on precision, non-invasive treatment modalities and structured ...

Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination ...

Lung cancer is the deadliest cancer, often detected late. Learn its symptoms, risks, and why quitting smoking and a healthy lifestyle can save lives.

Chattogram, Jan. 31 -- year-old inmate died on Saturday at Chittagong Medical College Hospital (CMCH) while receiving treatment for cancer.